Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Approval strengthens the company’s growing international anti-infective portfolio
Supported by Plan International, the partnership will help treat over 1,000 children annually
Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Subscribe To Our Newsletter & Stay Updated